BNTC insider transactions
Benitec Biopharma Inc. (BNTC) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for BNTC
- SEC Form 4 filed by Director Friedman David Matthew4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 3 filed by new insider Friedman David Matthew3 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Director Mates Sharon4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- Director Suvretta Capital Management, Llc bought $1,903,133 worth of shares (144,223 units at $13.20) (SEC Form 4)4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- Director Suvretta Capital Management, Llc bought $538,972 worth of shares (46,141 units at $11.68) (SEC Form 4)4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Benitec Biopharma Inc.4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Director Mehta Kishan4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Director Smith Edward F4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Benitec Biopharma Inc.4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Benitec Biopharma Inc.4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Mukadam Sophie4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Banks Jerel A.4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Boston Megan4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- Director Suvretta Capital Management, Llc bought $19,999,994 worth of shares (1,481,481 units at $13.50) (SEC Form 4)4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Director Mates Sharon4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 3 filed by new insider Mates Sharon3 - Benitec Biopharma Inc. (0001808898) (Issuer)
- Director Suvretta Capital Management, Llc bought $211,736 worth of shares (16,497 units at $12.83) (SEC Form 4)4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- Director Suvretta Capital Management, Llc bought $11,700,000 worth of shares (900,000 units at $13.00) (SEC Form 4)4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- Director Buchi J Kevin gifted 103,626 shares and received a gift of 103,626 shares, decreasing direct ownership by 100% to 284 units (SEC Form 4)4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- Director Buchi J Kevin exercised 51,813 shares at a strike of $3.86, increasing direct ownership by 99% to 103,910 units (SEC Form 4)4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- New insider Mukadam Sophie claimed ownership of 6,016 shares (SEC Form 3)3 - Benitec Biopharma Inc. (0001808898) (Issuer)
- Director Suvretta Capital Management, Llc bought $527,174 worth of shares (47,520 units at $11.09) (SEC Form 4)4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Director Mehta Kishan4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Director Francis Peter4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Director Buchi J Kevin4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Director Smith Edward F4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Banks Jerel A.4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Executive Director Boston Megan4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- Director Suvretta Capital Management, Llc bought $403,200 worth of shares (42,000 units at $9.60) (SEC Form 4)4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- Director Suvretta Capital Management, Llc bought $416,616 worth of shares (41,436 units at $10.05) (SEC Form 4)4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- Director Suvretta Capital Management, Llc exercised 7,137,763 in-the-money shares at a strike of $2.96 (SEC Form 4)4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 3 filed by new insider Mehta Kishan3 - Benitec Biopharma Inc. (0001808898) (Issuer)
- New insider Suvretta Capital Management, Llc claimed ownership of 1,691,290 shares (SEC Form 3)3 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Banks Jerel A.4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Boston Megan4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Smith Edward F4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Francis Peter4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Buchi J Kevin4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4: Boston Megan bought 25,907 shares4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4: Buchi J Kevin bought 51,813 shares, increasing direct ownership by 18,244% to 52,097 units4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Boston Megan4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Banks Jerel A.4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Smith Edward F4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Buchi J Kevin4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Francis Peter4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Buchi J Kevin4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Smith Edward F4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4 filed by Francis Peter4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 4: Oliveira Steven Michael bought $1,497,454 worth of shares (331,877 units at $4.51)4 - Benitec Biopharma Inc. (0001808898) (Issuer)
- SEC Form 3: New insider Oliveira Steven Michael claimed ownership of 668,123 shares3 - Benitec Biopharma Inc. (0001808898) (Issuer)